geneoscopy
The Specialty Development Executive is responsible for promoting the clinical and economic value of the ColoSense® colorectal cancer screening test to healthcare providers within an assigned Southeast territory. This role involves driving product adoption, providing ongoing education and support, and developing strategic business plans to support growth. The position requires frequent travel and collaboration with internal teams and external partners to achieve sales goals.
Headquarters
St. Louis, Missouri, United States
Company Size
51-200 employees
Founded
2015
Geneoscopy is a biotechnology company focused on transforming gastrointestinal health through innovative, noninvasive stool-based molecular diagnostics. Powered by its proprietary stool-derived eukaryotic RNA (seRNA) technology platform, the company develops tests for colorectal cancer screening and inflammatory bowel disease monitoring, including ColoSense®, the first FDA-approved RNA-based stool test for colorectal cancer screening in adults 45 and older. Geneoscopy's mission is to empower patients and healthcare providers with precise, accessible diagnostic tools that help prevent, detect, and monitor gastrointestinal disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for geneoscopy.
7% above the average for this role
Screening Sales Representative
Abbott Laboratories
Screening Sales Representative
Abbott Laboratories
Diagnostic Sales Representative, Early Cancer Detection - Phoenix, AZ
Exact Sciences Corporation
Specialty Development Executive
Labcorp
Screening Sales Representative
Abbott Laboratories
Territory Executive – Sacral Neuromodulation
bostonscientific